🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

1,374 notícias encontradas para "repor"
Foto: Darkshade Photos / Pexels
Supporting women in early labor is important for safe maternity care
The Nottingham University Hospitals NHS Trust report has identified serious failings in care at one of England's largest maternity services, with lessons for maternity units nationally. Among its findings was a repeated problem at the very start of labor: Women and families strug
Antibiotics reverse damage caused to blood stem cells by chronic Salmonella, study suggest
A new study from Ben-Gurion University of the Negev (BGU) has revealed that long-term Salmonella infections severely damage blood stem cells—the essential factory cells in bone marrow that produce all the body's blood and immune cells. However, the research, published in Cell Rep
How AI has moved from the sidelines to the center of health care
A new CSIRO report titled "AI Trends for Healthcare" reveals how AI is now embedded in real-world clinical settings for more connected, safer and more efficient health care.
Tick-borne diseases reported every month of the year and in every Illinois county
A new analysis of state health department data reveals that more than 6,400 Illinois residents were diagnosed with tick-borne diseases from 2004 to 2022. The most commonly reported infections in the state are Lyme disease, occurring across Illinois but at higher rates in northern
How athletes envision the future of sport during climate change
There is an urgent need for greater climate action across the sports industry, emphasizing the critical role athletes can play in shaping a more sustainable future for sport, according to a new briefing report.
Foto: roberto carrafa / Pexels
Investigators report promising results from Phase II trial of targeted therapy for rare bi
Results of the ongoing eNRGy trial, a single-arm, multicenter, global Phase II clinical trial evaluating zenocutuzumab in solid tumors positive for Neuregulin 1 (NRG1) gene fusions, reported manageable side effects and clinically meaningful efficacy—including a near doubling of p
Do treino à recuperação: os hábitos dos atletas de alto rendimento que você também pode ad
Do treino à recuperação: os hábitos dos atletas de alto rendimento que você também pode ad
Otimize sua recuperação pós-treino com a estratégia dos 5 Rs, essencial para atletas e entusiastas fitness. O recorte ajuda a contextualizar a pauta dentro de Fitness.
Men should speed up slower to avoid 'hitting the wall' in marathons, new research suggests
Men should speed up slower to avoid 'hitting the wall' in marathons, new research suggests
Male runners may be twice as likely as female runners to suddenly slow down—known as "hitting the wall"—during a marathon, according to a study published in Scientific Reports. The authors suggest that men may be able to reduce this risk by starting races more slowly and speeding
Rural Americans more likely to view cancer as a death sentence, poll finds
People living in rural America are more likely to view cancer as a death sentence, a new survey reports. About 43% of people living in rural areas say a cancer diagnosis means inevitable death, compared to 35% of people in urban or suburban locales, according to the new poll from
Analysis indicates Latinos in U.S. are indispensable to nation's prosperity, health, futur
The conventional narrative that Latinos are taking more from the United States than they contribute is not just wrong—it is dangerous. In a new "Medicine and Society" analysis published in the New England Journal of Medicine, researchers from the Center for Latino Adolescent and
Repurposed cancer drug rapidly eased rare autoimmune neuropathy in two patients
An interdisciplinary team at Jena University Hospital achieved a surprisingly rapid and significant improvement in two patients with an autoimmune peripheral nervous system disorder. The team administered teclistamab, a drug originally developed for multiple myeloma, and reported
More than 1.15 million fertility treatment cycles in Europe in 2023 as impact of frozen em
More than 1.15 million fertility treatment cycles in Europe in 2023 as impact of frozen em
More than 1.15 million assisted reproductive technology (ART) treatment cycles were reported across Europe in 2023, according to preliminary data presented by the European IVF Monitoring (EIM) Consortium at the 42nd Annual Meeting of the European Society of Human Reproduction and